<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129">
  <!-- This xml conforms to:  http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>Information obtained from ClinicalTrials.gov on October 20, 2011</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01219972</url>
  </required_header>
  <id_info>
    <org_study_id>CRC 04118</org_study_id>
    <nct_id>NCT01219972</nct_id>
  </id_info>
  <brief_title>Pulmonary Complications of Allografts</brief_title>
  <acronym>ALLOPULM</acronym>
  <official_title>Prospective Cohort Study of Late Pulmonary Complications in Patients Who Received Allogeneic Hematopoietic Stem Cells Transplantation: Estimation of Incidence and Identification of Distinct Nosologic Entities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prognostic study of the late lung complications arising at the patient's having
      received an allograft of hematopoetic stem cells.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Objectives To estimate the incidence of late (at least occurring 100 days after
           transplantation) pulmonary complications following allogeneic blood stem cells
           transplantation

        -  Study Design Prospective Cohort Study

        -  Sample Size 200 transplanted patients

        -  Endpoints Non infectious pulmonary complications within the first 3 years
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model:  Cohort, Time Perspective:  Prospective</study_design>
  <primary_outcome>
    <measure>Non infectious pulmonary complication</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival after non infectious pulmonary complication</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">245</enrollment>
  <condition>Pulmonary Complications</condition>
  <arm_group>
    <arm_group_label>Allografted patients</arm_group_label>
    <description>All consecutive patients who underwent an allogeneic blood stem cells transplantation performed at saint Louis hospital during the study recruitment period
if alive at 100 days post-transplant
and who gave informed consent</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent a allogeneic blood stem cell transplantation, alive at 100 days
        post-transplantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Allogeneic Blood stem cell transplantation

          -  Alive at day 100 post-transplant

        Exclusion Criteria:

          -  Non informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Bergeron - Laffaurie,, PhDMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <lastchanged_date>October 21, 2010</lastchanged_date>
  <firstreceived_date>October 11, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Marie Castera</name_title>
    <organization>Department of Clinical Research of developpement</organization>
  </responsible_party>
  <keyword>Bone marrow transplant</keyword>
  <keyword>Pulmonary complications</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
</clinical_study>
